Robert Ferris: Clinical Trials

2 trials sponsored by Robert Ferris, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Withdrawn 1

Follow Robert Ferris: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Biological Vaccine: Semi-allogeneic Human Fibroblasts (MRC-5) Transfected With DNA
Semi-allogenic human fibroblast (MRC-5) transfected with DNA - Head and Neck Squamous Cell Carcinoma (HNSCC)
Phase 1WithdrawnRobert Ferris2016-09-012017-09-07
Vaccine Therapy in Treating Patients With Head and Neck Cancer
mutant p53 peptide pulsed dendritic cell vaccine, tetanus toxoid helper peptide, adjuvant therapy - Head and Neck Cancer
Phase 1CompletedRobert Ferris172005-09-012016-04-18

Conditions studied

Head and Neck Neoplasms (2)  ·  Squamous Cell Carcinoma of Head and Neck (2)  ·  Carcinoma (1)  ·  Carcinoma, Squamous Cell (1)  ·  Tongue Neoplasms (1)

Interventions

Chemotherapy, Adjuvant (1)  ·  DNA (1)

Countries

United States (2)

Top investigators

Robert L Ferris, MD (1)  ·  Robert L. Ferris, MD, PhD (1)